- New ETFs
- Bond ETFs
- Currency ETFs
- Emerging Market ETFs
- Commodity ETFs
- Broad U.S. Equity ETFs
- Sector ETFs
- Specialty ETFs
Today, Verichip (NASDAQ: CHIP) announce that they will be collaborating in Cure Focused Research, the Diabetes Research Institute. They hope to collaborate together in producing a Glucose Sensing Radio Frequency Microchip that can sense glucose levels in someone’s blood. VeriChip is currently partnered with research company, RECEPTORS, for the development of this new product.
This chip is used in order to provide both the patient and doctor with easy to access information through VeriChip’s interoperable personal health record named Health Link.
In addition to creating the Microchip, VeriChip and DRI will also be conducting the unbiased, randomized clinical study to determine the effectiveness of the new microchip.
I am interested in contacting someone that would help produce an item similiar to the current devise used for the detection of sugar in liquids,,Unrelated to the medical field..Thank you
I am interested in contacting someone that would help me produce an item similiar to the current devise used for the detection of sugar in liquids,,Unrelated to the medical field..Thank you